Ketamine-snorting associated cystitis

Ketamine hydrochloride, commonly used as a pediatric anesthetic agent, is an N-methyl-d-aspartic (NMDA) acid receptor antagonist with rapid onset and short duration of action. It produces a cataleptic-like state where the patient is dissociated from the surrounding environment by direct action on th...

Full description

Bibliographic Details
Main Authors: Chung-Hsien Chen, Ming-Huei Lee, Yi-Chang Chen, Ming-Fong Lin
Format: Article
Language:English
Published: Elsevier 2011-12-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664611001355
_version_ 1819027290902757376
author Chung-Hsien Chen
Ming-Huei Lee
Yi-Chang Chen
Ming-Fong Lin
author_facet Chung-Hsien Chen
Ming-Huei Lee
Yi-Chang Chen
Ming-Fong Lin
author_sort Chung-Hsien Chen
collection DOAJ
description Ketamine hydrochloride, commonly used as a pediatric anesthetic agent, is an N-methyl-d-aspartic (NMDA) acid receptor antagonist with rapid onset and short duration of action. It produces a cataleptic-like state where the patient is dissociated from the surrounding environment by direct action on the cortex and limbic system. It has emerged as an increasingly popular choice among young drug users, especially within dance club venues. Cases of bladder dysfunction among recreational ketamine users were reported since Shahani et al first reported nine cases of ketamine-associated ulcerative cystitis in 2007. We report on four patients who had history of ketamine abuse, presenting with dysuria, fluctuating lower urinary tract symptoms (LUTS), lower abdominal or perineal pain, and impaired functional bladder capacities. Urinalysis showed pyuria and microhematuria. Urine culture was sterile. Bladder ulceration with severe diffuse hemorrhage and low bladder capacity were noted under anesthetized cystoscopic examination. Transurethral bladder mucosa biopsy was consistent with chronic cystitis. Cessation of ketamine abuse was the milestone of treatment, followed by the administration of mucosal protective agents, such as pentosan polysulphate or hyaluronic acid. Suprapubic pain was improved in three patients during follow-up. However, the outcome of treatment depends on the severity of the disease process, similar to that of interstitial cystitis (IC).
first_indexed 2024-12-21T05:40:08Z
format Article
id doaj.art-db93cd1ba4934990b0fb5e86f4d4f921
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-21T05:40:08Z
publishDate 2011-12-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-db93cd1ba4934990b0fb5e86f4d4f9212022-12-21T19:14:17ZengElsevierJournal of the Formosan Medical Association0929-66462011-12-011101278779110.1016/j.jfma.2011.11.010Ketamine-snorting associated cystitisChung-Hsien Chen0Ming-Huei Lee1Yi-Chang Chen2Ming-Fong Lin3Department of Urology, Taichung Hospital, Department of Health, Executive Yuan, Taichung, Taiwan, ROCDepartment of Urology, Taichung Hospital, Department of Health, Executive Yuan, Taichung, Taiwan, ROCDepartment of Urology, Taichung Hospital, Department of Health, Executive Yuan, Taichung, Taiwan, ROCDepartment of Urology, Taichung Hospital, Department of Health, Executive Yuan, Taichung, Taiwan, ROCKetamine hydrochloride, commonly used as a pediatric anesthetic agent, is an N-methyl-d-aspartic (NMDA) acid receptor antagonist with rapid onset and short duration of action. It produces a cataleptic-like state where the patient is dissociated from the surrounding environment by direct action on the cortex and limbic system. It has emerged as an increasingly popular choice among young drug users, especially within dance club venues. Cases of bladder dysfunction among recreational ketamine users were reported since Shahani et al first reported nine cases of ketamine-associated ulcerative cystitis in 2007. We report on four patients who had history of ketamine abuse, presenting with dysuria, fluctuating lower urinary tract symptoms (LUTS), lower abdominal or perineal pain, and impaired functional bladder capacities. Urinalysis showed pyuria and microhematuria. Urine culture was sterile. Bladder ulceration with severe diffuse hemorrhage and low bladder capacity were noted under anesthetized cystoscopic examination. Transurethral bladder mucosa biopsy was consistent with chronic cystitis. Cessation of ketamine abuse was the milestone of treatment, followed by the administration of mucosal protective agents, such as pentosan polysulphate or hyaluronic acid. Suprapubic pain was improved in three patients during follow-up. However, the outcome of treatment depends on the severity of the disease process, similar to that of interstitial cystitis (IC).http://www.sciencedirect.com/science/article/pii/S0929664611001355cystitisinterstitial cystitisketamine
spellingShingle Chung-Hsien Chen
Ming-Huei Lee
Yi-Chang Chen
Ming-Fong Lin
Ketamine-snorting associated cystitis
Journal of the Formosan Medical Association
cystitis
interstitial cystitis
ketamine
title Ketamine-snorting associated cystitis
title_full Ketamine-snorting associated cystitis
title_fullStr Ketamine-snorting associated cystitis
title_full_unstemmed Ketamine-snorting associated cystitis
title_short Ketamine-snorting associated cystitis
title_sort ketamine snorting associated cystitis
topic cystitis
interstitial cystitis
ketamine
url http://www.sciencedirect.com/science/article/pii/S0929664611001355
work_keys_str_mv AT chunghsienchen ketaminesnortingassociatedcystitis
AT minghueilee ketaminesnortingassociatedcystitis
AT yichangchen ketaminesnortingassociatedcystitis
AT mingfonglin ketaminesnortingassociatedcystitis